Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_assertion type Assertion NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_head.
- NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_assertion description "[Clinical impact of continued crizotinib administration after isolated central nervous system progression in patients with lung cancer positive for ALK rearrangement.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_provenance.
- NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_assertion evidence source_evidence_literature NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_provenance.
- NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_assertion SIO_000772 23584297 NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_provenance.
- NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_assertion wasDerivedFrom befree-2016 NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_provenance.
- NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_assertion wasGeneratedBy ECO_0000203 NP1069096.RAvLFHdADQWL-aEmgDKiJFPoxgMU9sLnFTlY3BVDwJ1ds130_provenance.